Guy Goodwin
Fortune : 28 215 $ au 30/06/2026
Fortune : 28 215 $ au 30/06/2026
Guy Goodwin is currently Chief Medical Officer at Compass Pathways Plc since 2021.
Formerly, Dr. Goodwin was Head of the Psychiatry Department at the University of Oxford, President of the European College of Neuropsychopharmacology, and President of the British Association for Psychopharmacology.
Education includes a doctorate from the University of Oxford.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/04/2026 | 1 994 ( 0 % ) | 28 215 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| COMPASS PATHWAYS PLC | Directeur Technique/Scientifique/R&D | 01/08/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
British Association For Psychopharmacology | President | - |
European College of Neuropsychopharmacology
European College of Neuropsychopharmacology Other Consumer ServicesConsumer Services Operates as a non-profit scientific association that serves as a platform to exchange and promote research in the field of neuropsychopharmacology | President | - |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European College of Neuropsychopharmacology
European College of Neuropsychopharmacology Other Consumer ServicesConsumer Services Operates as a non-profit scientific association that serves as a platform to exchange and promote research in the field of neuropsychopharmacology | Consumer Services |
Compass Pathways Plc
Compass Pathways Plc BiotechnologyHealth Technology Develops therapies and drugs for the treatment of mental health and neurocognitive conditions | Health Technology |
British Association For Psychopharmacology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national